Segui
Michael Platten
Michael Platten
Professor of Neurology, German Cancer Research Center and Heidelberg University
Email verificata su dkfz.de - Home page
Titolo
Citata da
Citata da
Anno
DNA methylation-based classification of central nervous system tumours
D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ...
Nature 555 (7697), 469-474, 2018
22252018
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
CA Opitz, UM Litzenburger, F Sahm, M Ott, I Tritschler, S Trump, ...
Nature 478 (7368), 197-203, 2011
18452011
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
W Wick, M Platten, C Meisner, J Felsberg, G Tabatabai, M Simon, ...
The lancet oncology 13 (7), 707-715, 2012
12082012
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
M Weller, M van den Bent, M Preusser, E Le Rhun, JC Tonn, G Minniti, ...
Nature reviews Clinical oncology 18 (3), 170-186, 2021
10952021
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
M Platten, EAA Nollen, UF Röhrig, F Fallarino, CA Opitz
Nature reviews Drug discovery 18 (5), 379-401, 2019
9212019
Brain tumour cells interconnect to a functional and resistant network
M Osswald, E Jung, F Sahm, G Solecki, V Venkataramani, J Blaes, S Weil, ...
Nature 528 (7580), 93-98, 2015
9192015
Lomustine and bevacizumab in progressive glioblastoma
W Wick, T Gorlia, M Bendszus, M Taphoorn, F Sahm, I Harting, ...
New England Journal of Medicine 377 (20), 1954-1963, 2017
8892017
A vaccine targeting mutant IDH1 induces antitumour immunity
T Schumacher, L Bunse, S Pusch, F Sahm, B Wiestler, J Quandt, O Menn, ...
Nature 512 (7514), 324-327, 2014
7642014
Actively personalized vaccination trial for newly diagnosed glioblastoma
N Hilf, S Kuttruff-Coqui, K Frenzel, V Bukur, S Stevanović, ...
Nature 565 (7738), 240-245, 2019
7432019
Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion
M Platten, W Wick, BJ Van den Eynde
Cancer research 72 (21), 5435-5440, 2012
7392012
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis
F Sahm, D Schrimpf, D Stichel, DTW Jones, T Hielscher, S Schefzyk, ...
The lancet oncology 18 (5), 682-694, 2017
7042017
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
PY Wen, M Weller, EQ Lee, BM Alexander, JS Barnholtz-Sloan, ...
Neuro-oncology 22 (8), 1073-1113, 2020
6992020
Aryl hydrocarbon receptor control of a disease tolerance defence pathway
A Bessede, M Gargaro, MT Pallotta, D Matino, G Servillo, C Brunacci, ...
Nature 511 (7508), 184-190, 2014
6542014
MGMT testing—the challenges for biomarker-based glioma treatment
W Wick, M Weller, M Van Den Bent, M Sanson, M Weiler, A Von Deimling, ...
Nature Reviews Neurology 10 (7), 372-385, 2014
5832014
Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite
M Platten, PP Ho, S Youssef, P Fontoura, H Garren, EM Hur, R Gupta, ...
Science 310 (5749), 850-855, 2005
5172005
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for …
DE Reuss, F Sahm, D Schrimpf, B Wiestler, D Capper, C Koelsche, ...
Acta neuropathologica 129, 133-146, 2015
5012015
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro …
M Uhl, S Aulwurm, J Wischhusen, M Weiler, JY Ma, R Almirez, ...
Cancer research 64 (21), 7954-7961, 2004
4862004
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
TV Lanz, RC Brewer, PP Ho, JS Moon, KM Jude, D Fernandez, ...
Nature 603 (7900), 321-327, 2022
4642022
Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
L Bunse, S Pusch, T Bunse, F Sahm, K Sanghvi, M Friedrich, D Alansary, ...
Nature medicine 24 (8), 1192-1203, 2018
4192018
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
B Wiestler, D Capper, T Holland-Letz, A Korshunov, A Von Deimling, ...
Acta neuropathologica 126, 443-451, 2013
4122013
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20